Abingworth Closes New Fund
This article was originally published in Start Up
Executive Summary
Abingworth's new fund puts the London-based venture firm in position to continue investing heavily on both sides of the Atlantic.
You may also be interested in...
Diversification vs. Sector Focus: Longitude, Enterprise Seek Latitude in Life Sciences
The age of specialization is not over for venture capital firms. The health care team from Pequot Ventures left the hedge-fund heavy firm to start Longitude Capital. Meanwhile, Enterprise Partners Venture Capital is said to be raising a health care only fund.
Diversification vs. Sector Focus: Longitude, Enterprise Seek Latitude in Life Sciences
The age of specialization is not over for venture capital firms. The health care team from Pequot Ventures left the hedge-fund heavy firm to start Longitude Capital. Meanwhile, Enterprise Partners Venture Capital is said to be raising a health care only fund.
Illumina Buys Solexa
The $600 million Illumina is paying to acquire next-generation sequencing company Solexa says more about current market drivers and meeting Illumina's immediate need for growth than it does about the technology's future application as a means of achieving the oft-touted goal of the $1,000 genome sequence.